Serum levels of reactive oxygen metabolites at 12 weeks during tocilizumab therapy are predictive of 52 weeks-disease activity score-remission in patients with rheumatoid arthritis
2019 · BMC Rheumatology · 2 citations
https://doi.org/10.1186/s41927-019-0096-1